This Article Abstract Full Text (PDF) All Versions of this Article: 44/6/952    most recent 01.HYP.0000147661.80059.cav1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Koeppen, M. Articles by de Wit, C. Search for Related Content PubMed PubMed Citation Articles by Koeppen, M. Articles by de Wit, C. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB NITRIC OXIDE Related Collections Endothelium/vascular type/nitric oxide

(Hypertension. 2004;44:952.)
© 2004 American Heart Association, Inc.

Scientific Contributions

cGMP-Dependent Protein Kinase Mediates NO- but not Acetylcholine-Induced Dilations in Resistance Vessels In Vivo

Michael Koeppen; Robert Feil; Daniel Siegl; Susanne Feil; Franz Hofmann; Ulrich Pohl; Cor de Wit

From the Physiologisches Institut (C.d.W.), Universität Lübeck, Germany; Physiologisches Institut (M.K., D.S., U.P.), Ludwig-Maximilians-Universität München, Germany; and Institut für Pharmakologie und Toxikologie (R.F., S.F., F.H.), Technische Universität München.

Correspondence to Dr Cor de Wit, Physiologisches Institut, Universität Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany. E-mail dewit{at}physio.uni-luebeck.de

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
cGMP and cGMP-dependent protein kinase type I (cGKI) mediate the dilation of large vessels in response to NO and acetylcholine (ACh). However, the physiological significance of the NO/cGMP/cGKI pathway in resistance vessels is controversial. Here, we analyzed NO- and ACh-induced dilations of arterioles in cGKI-deficient (cGKI^–/–) or endothelial NO synthase–deficient (eNOS^–/–) mice. Mean arterial pressure was similar in cGKI^–/– and wild-type mice (105 mm Hg). Pressure drops in response to intracarotid bolus application of the NO donor sodium nitroprusside (SNP) were almost abolished in cGKI^–/– mice, whereas ACh-induced pressure decreases remained intact in cGKI^–/– and eNOS^–/– mice. The direct observation of arterioles in the cremaster muscle by intravital microscopy showed impaired SNP-induced dilations in cGKI^–/– mice (by 80%) and normal ACh-induced dilations in cGKI^–/– and eNOS^–/– mice. ACh-induced dilations in eNOS^–/– mice were attenuated by iberiotoxin (by 50%), indicating that they were mediated in part by Ca²⁺-activated K⁺ channels, but not by inhibitors of cyclooxygenase or p450-monooxygenases. We conclude that cGMP and cGKI are the major effectors of NO to induce acute dilations of murine resistance vessels. However, the NO/cGMP/cGKI pathway is not essential for ACh-induced dilation of arterioles and for basal blood pressure regulation in mice.

Key Words: nitric oxide • endothelium • microcirculation

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
Nitric oxide plays an integral role in the control of vascular tone. Relaxation of smooth muscle by NO is mediated, at least in part, by a rise of the second messenger cGMP, which has several targets, such as cGMP-regulated cyclic nucleotide phosphodiesterases, cGMP-dependent protein kinase type I (cGKI), and, at high concentrations, cAMP-dependent protein kinase.¹ In vitro studies with isolated vessels of cGKI-deficient (cGKI^–/–) mice showed that cGKI contributes to relaxation of the aorta and arteria tibialis in response to NO.^2,3 However, the role of the NO/cGMP/cGKI pathway in resistance vessels in vivo is controversially discussed. Endothelium-dependent dilation of arterioles triggered by acetylcholine (ACh) might involve NO, prostacyclin, as well as endothelium-derived hyperpolarizing factor (EDHF).⁴ Although ACh dilations are mediated in large vessels in mice nearly exclusively by NO/cGMP/cGKI,^2,5 EDHF seems to play an important role in smaller arteries and arterioles, possibly via activation of Ca²⁺-dependent K⁺-channels,⁶ which suggests that dilator pathways might be very distinct with respect to vessel size. In this study, we investigated the physiological relevance of the NO/cGMP/cGKI pathway to the regulation of tone in resistance vessels by recording arterial pressure and by intravital microscopy of the cremaster microcirculation in cGKI^–/–7 or endothelial NO synthase–deficient (eNOS^–/–) mice.⁸

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Animals and Arterial Pressure Recording
Experiments were performed in 6- to 8-week-old cGKI^–/–7 or eNOS^–/– mice⁸ and litter- or age-matched wild-type (wt) controls on a 129/Sv (cGKI^–/–) or C57BL/6 (eNOS^–/–) genetic background, in accordance with the German animal protection law. Mean arterial pressure (MAP) was measured in awake female animals via a catheter that was inserted in the right carotid artery during short anesthesia as described.⁹ After obtaining baseline pressure values during a 1-hour period, sodium nitroprusside (SNP) or ACh was injected as a single bolus into the carotid artery at increasing dosages (from 0.05 to 15 nmol) in a volume of 50 µL. Pressure was allowed to return to control values before the next bolus was applied, which normally occurred within 5 to 10 minutes depending on the dosage used. All mice were killed by an overdose of anesthesia at the end of the protocol.

Microcirculatory Studies
Intravital microscopy was performed in the cremaster muscle of anesthetized mice (droperidol [20 mg/kg], fentanyl [0.1 mg/kg], midazolam [2 mg/kg] IV) as described.¹⁰ In each animal, 7 to 12 arterioles were observed using a microscope (Metallux; Leitz) equipped with a video camera. Diameters were measured shortly before and during the local superfusion of ACh (0.1 to 10 µmol/L), SNP (0.1 to 10 µmol/L), or S-nitroso-N-acetyl-D,L-penicillamine (SNAP; 1 to 10 µmol/L). Increasing concentrations of vasoactive drugs were applied consecutively, with a recovery period of 5 minutes after washout. In some experiments, dilator responses were restudied in the presence of the cyclooxygenase inhibitor indomethacin (3 µmol/L), the reversible inhibitor of p450-monooxygenases sulfaphenazole (20 µmol/L), the suicide inhibitor of the p450-monooxygenase 17-octadecynoic acid (ODYA; 100 µmol/L), or the specific blocker of large-conductance Ca²⁺-dependent K⁺-channels (BK_Ca) iberiotoxin (0.1 µmol/L). The applied concentrations of these inhibitors have been shown previously to be effective in hamster microcirculation.¹¹ The inhibitors were added continuously to the superfusion 30 minutes before the protocol was repeated, except for iberiotoxin, which was applied for only 15 minutes before restudying the dilator responses. Experiments lasted typically between 3 and 5 hours. The maximal diameter of the arterioles was measured during superfusion of a combination of different vasodilators (adenosine [100 µmol/L], SNP [100 µmol/L], and ACh [100 µmol/L]) at the end of the experimental protocol, and the animal was euthanized by an overdose of anesthesia.

Statistics and Calculations
Vascular tone is given as the quotient of the resting diameter of the vessel divided by its maximum. Changes of the inner diameter of the vessels were normalized to the maximal possible constriction or dilation according to the following relationship. Percentage of maximal response=(D_Tr–D_Co)/(D_M–D_Co)x100, where D_Tr is the diameter observed after treatment and D_Co is the control diameter before treatment. D_M is (for dilator responses) the diameter at maximal dilation or (for constrictions) the minimal luminal diameter (zero). Comparisons within groups were performed using paired t tests, and for multiple comparisons, P values were corrected according to Bonferroni. Data between groups were compared by ANOVA followed by post hoc analysis of the means, with P<0.05 considered significant. Data are presented as mean±SEM.

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
Responses on Systemic Application of SNP and ACh
MAP in conscious cGKI^–/– mice (106±6 mm Hg; n=6 animals; age 51±7 days) was not different from wt littermates (104±6 mm Hg; n=8 animals; age 48±5 days). Heart rate was also similar in both genotypes (wt 393±34 bpm; cGKI^–/– 369±50 bpm). Bolus injections of the NO donor SNP into the carotid artery induced dose-dependent transient decreases of MAP in wt mice (Figure 1A). With increasing concentrations, magnitude as well as duration of the response increased. Both factors contributed to the increment of the calculated area under the curve (AUC) with higher SNP concentrations (Figure 1C). In contrast, SNP-induced pressure drops were nearly absent in cGKI^–/– animals (Figure 1B and 1C). MAP was elevated in eNOS^–/– mice (127±8 mm Hg). However, SNP-induced decreases of MAP in eNOS^–/– mice were comparable to wt controls (Figure 1C). Surprisingly, systemic application of ACh induced similar maximal pressure drops in wt, cGKI^–/–, and eNOS^–/– mice (Figure 1D).

View larger version (32K): [in this window] [in a new window]   Figure 1. Changes of MAP in response to systemic application of SNP or ACh. The intracarotid bolus application of drugs is indicated by bars. SNP-induced pressure drops were nearly absent in cGKI–/– mice (n=4 animals; B and C) compared with wt (n=7 animals; A and C) and eNOS–/– mice (n=6 animals; C). C shows the AUC calculated from the pressure responses of the respective genotypes (*P<0.05 vs wt mice). Pressure drops in response to ACh (1.5 nmol) were similar in wt (n=5), cGKI–/– (n=3), and eNOS–/– (n=6) mice (D).

Dilations in the Cremaster Muscle Microcirculation In Vivo
Arterioles with a diameter between 14 and 94 µm were studied (wt 31±3, n=42 in 4 animals; cGKI^–/– 27±2 µm, n=67 in 6 animals; P=0.22). Arteriolar resting tone was not different between genotypes (wt 0.34±0.03; cGKI^–/– 0.35±0.02) reflecting the normotension in cGKI^–/– mice. SNP induced a concentration-dependent arteriolar dilation in wt mice (Figure 2A). Significant dilations were already observed at the lowest SNP concentration used (0.1 µmol/L). In contrast, SNP-induced dilations in cGKI^–/– mice were absent at low (0.3 µmol/L) and strongly reduced at higher (1.0 µmol/L) SNP concentrations compared with wt controls (Figure 2A). Similar results were obtained using the NO donor SNAP. Dilations in response to 1 µmol/L and 10 µmol/L SNAP in wt mice were 30±5% and 63±5%, and in cGKI^–/– mice, 11±3 and 15±3% (P<0.05 versus wt). Endothelium-dependent dilations on ACh application were preserved in cGKI^–/– and eNOS^–/– arterioles (Figure 2B and 2C).

View larger version (22K): [in this window] [in a new window]   Figure 2. Arteriolar dilations in the cremaster muscle microcirculation in vivo. A, SNP-induced dilations were strongly attenuated in cGKI–/– mice (n=67 arterioles in 6 animals) compared with wt controls (n=42 arterioles in 4 animals). Significant differences are indicated by the asterisk (P<0.05). B, In contrast, ACh-induced dilations in these same vessels were similar in both genotypes. C and D illustrate ACh-induced dilations in eNOS–/– mice. C, Responses were not affected by indomethacin (indo; 3 µmol/L; n=78 arterioles in 6 mice) but significantly attenuated by additional iberiotoxin (IbTx; 0.1 µmol/L; n=41 arterioles in 4 animals; *P<0.05 vs indo). D, ACh responses remained unaffected by inhibitors of the p450 pathway (20 µmol/L sulfaphenazole [sulfa], n=52 arterioles in 5 mice; 100 µmol/L ODYA, n=44 arterioles in 4 animals). Data are presented as percentage of maximal dilation induced by superfusion of a combination of different vasodilators (100 µmol/L adenosine; 100 µmol/L SNP; 100 µmol/L ACh) at the end of each experiment.

Effect of Different Inhibitors on ACh-Induced Dilations
Indomethacin (3 µmol/L) did not induce significant diameter changes in cGKI^–/– mice or attenuate ACh-induced dilations (data not shown). Likewise, indomethacin did not attenuate ACh-induced dilations in eNOS^–/– mice (Figure 2C). Additional application of inhibitors of p450-monooxygenases (20 µmol/L sulfaphenazole or 100 µmol/L ODYA) did not affect arteriolar resting diameter (data not shown) or ACh-induced dilations in eNOS^–/– mice (Figure 2D). However, iberiotoxin (0.1 µmol/L), a specific blocker of large-conductance Ca²⁺-activated K⁺ (BK_Ca) channels, significantly attenuated ACh dilations in eNOS^–/– mice (Figure 2C), whereas vascular tone (before 0.24±0.02; after 0.23±0.03) or dilations in response to SNP (10 µmol/L) were not altered (71±4 versus 62±4%).

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

 
Results of the MAP measurements and intravital microscopy of arterioles correlate well with each other and strongly support the following 2 conclusions. First, the acute dilation of resistance vessels by NO is mediated predominantly by cGKI. Dilation is in part cGKI independent only at high, presumably pathological, concentrations of NO. The dilation of cremaster arterioles by NO does not require activation of BK_Ca channels. These findings are in line with previous results³ showing that NO can relax the arteria tibialis (which may behave similar to resistance vessels) via cGKI-dependent and cGKI-independent mechanisms that do not absolutely require the activation of BK_Ca channels. Arteriolar dilation by the NO/cGMP/cGKI pathway might involve translocation of the small GTPase RhoA, activation of the myosin phosphatase,¹² a decrease in the Ca²⁺ sensitivity of the contractile machinery,¹³ and/or an inhibition of intracellular Ca²⁺ release.^14,15 Despite the critical role of cGKI, conscious cGKI^–/– animals were normotensive. This is in agreement with a previous study² that reported that cGKI^–/– animals were hypertensive only at very young age (32 days) but normotensive at older age (43 days). Thus, cGKI is apparently not essential for basal blood pressure regulation in 6- to 8-week-old mice.

Second, endothelium-dependent dilations of resistance vessels triggered by ACh do not require eNOS-derived NO or cGKI because dilations initiated by ACh were preserved in eNOS^–/– and cGKI^–/– mice in the microcirculation, and only a shortening of the pressure drop after systemic ACh application was observed. This is in marked contrast to larger vessels, such as the aorta and arteria tibialis, in which ACh-induced relaxation is mediated exclusively by a pathway involving eNOS⁵ and cGKI.^2,3 Our findings that ACh-induced decreases in MAP as well as ACh-induced dilations of cremaster arterioles were almost intact in eNOS^–/– and cGKI^–/– mice, together with previous reports showing normal ACh responses in various vascular beds of eNOS^–/– mice,¹⁶ strongly suggest that the NO/cGMP/cGKI pathway is not essential for ACh-triggered dilation of resistance vessels. The ACh-induced dilation of cremaster arterioles in eNOS^–/– mice was not affected by indomethacin but attenuated by iberiotoxin. This indicates that the ACh response was not mediated by prostaglandins but at least in part by an EDHF-like activity resulting in the opening of BK_Ca channels, hyperpolarization, and smooth muscle relaxation. In contrast to coronary¹⁷ and skeletal muscle¹⁸ arteries, this EDHF was apparently not related to metabolites of the cytochrome p450 pathway because 2 chemically distinct blockers of this pathway were without effect. The identity of the EDHF-like activity in cremaster arterioles remains unknown.

Perspectives
This study shows that hypotheses about vasodilator pathways cannot be generalized and need critical evaluation in different vascular beds, especially in vessels of different sizes. As in larger arteries,² cGKI is an important effector of the acute effects of NO in resistance vessels. However, the NO/cGMP/cGKI pathway in arterioles is not essential for ACh-induced dilations and basal blood pressure control in mice. These results support the notion that cGMP-dependent pathways in smooth muscle may be more important in acute versus chronic blood pressure regulation¹⁹ and that the systemic hypertension of eNOS^–/– mice might be caused not only by a defect in endothelium-dependent vasorelaxation but also by other changes in the knockout animals, such as a disturbed baroreceptor response or an increased release of renin from the kidney into the bloodstream.^5,20

	Acknowledgments

 
This work was supported by the Deutsche Forschungsgemeinschaft (WI 2071/1-1), the Friedrich-Baur Stiftung, and the VolkswagenStiftung. We thank Dr Axel Gödecke (Zentrum für Physiologie, Düsseldorf, Germany) for kindly supplying eNOS-deficient mice.

Received August 23, 2004; first decision September 7, 2004; accepted October 4, 2004.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 
1. Schopfer FJ, Baker PR, Freeman BA. NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response? Trends Biochem Sci. 2003; 28: 646–654.[CrossRef][Medline] [Order article via Infotrieve]

2. Pfeifer A, Klatt P, Massberg S, Ny L, Sausbier M, Hirneiss C, Wang GX, Korth M, Aszodi A, Andersson KE, Krombach F, Mayerhofer A, Ruth P, Fassler R, Hofmann F. Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J. 1998; 17: 3045–3051.[CrossRef][Medline] [Order article via Infotrieve]

3. Sausbier M, Schubert R, Voigt V, Hirneiss C, Pfeifer A, Korth M, Kleppisch T, Ruth P, Hofmann F. Mechanisms of NO/cGMP-dependent vasorelaxation. Circ Res. 2000; 87: 825–830.[Abstract/Free Full Text]

4. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, Weston AH. EDHF: bringing the concepts together. Trends Pharmacol Sci. 2002; 23: 374–380.[CrossRef][Medline] [Order article via Infotrieve]

5. Huang PL, Huang ZH, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995; 377: 239–242.[CrossRef][Medline] [Order article via Infotrieve]

6. Brandes RP, Schmitz-Winnenthal FH, Feletou M, Gödecke A, Huang PL, Vanhoutte PM, Fleming I, Busse R. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci U S A. 2000; 97: 9747–9752.[Abstract/Free Full Text]

7. Wegener JW, Nawrath H, Wolfsgruber W, Kuhbandner S, Werner C, Hofmann F, Feil R. cGMP-dependent protein kinase I mediates the negative inotropic effect of cGMP in the murine myocardium. Circ Res. 2002; 90: 18–20.[Abstract/Free Full Text]

8. Gödecke A, Decking UK, Ding Z, Hirchenhain J, Bidmon HJ, Gödecke S, Schrader J. Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res. 1998; 82: 186–194.[Abstract/Free Full Text]

9. de Wit C, Roos F, Bolz SS, Pohl U. Lack of vascular connexin 40 is associated with hypertension and irregular arteriolar vasomotion. Physiol Genomics. 2003; 13: 169–177.[Abstract/Free Full Text]

10. de Wit C, Roos F, Bolz SS, Kirchhoff S, Krüger O, Willecke K, Pohl U. Impaired conduction of vasodilation along arterioles in connexin40 deficient mice. Circ Res. 2000; 86: 649–655.[Abstract/Free Full Text]

11. Hoepfl B, Rodenwaldt B, Pohl U, de Wit C. EDHF, but not NO or prostaglandins, is critical to evoke a conducted dilation upon ACh in hamster arterioles. Am J Physiol Heart Circ Physiol. 2002; 283: H996–H1004.[Abstract/Free Full Text]

12. Bolz SS, Vogel L, Sollinger D, Derwand R, de Wit C, Loirand G, Pohl U. Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway. Circulation. 2003; 107: 3081–3087.[Abstract/Free Full Text]

13. Surks HK, Mochizuki N, Kasai Y, Georgescu SP, Tang KM, Ito M, Lincoln TM, Mendelsohn ME. Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase I alpha. Science. 1999; 286: 1583–1587.[Abstract/Free Full Text]

14. Schlossmann J, Ammendola A, Ashman K, Zong XG, Huber A, Neubauer G, Wang GX, Allescher HD, Korth M, Wilm M, Hofmann F, Ruth P. Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase I beta. Nature. 2000; 404: 197–201.[CrossRef][Medline] [Order article via Infotrieve]

15. Feil R, Gappa N, Rutz M, Schlossmann J, Rose CR, Konnerth A, Brummer S, Kuhbandner S, Hofmann F. Functional reconstitution of vascular smooth muscle cells with cGMP-dependent protein kinase I isoforms. Circ Res. 2002; 90: 1080–1086.[Abstract/Free Full Text]

16. Gödecke A, Schrader J. Adaptive mechanisms of the cardiovascular system in transgenic mice—lessons from eNOS and myoglobin knockout mice. Basic Res Cardiol. 2000; 95: 492–498.[CrossRef][Medline] [Order article via Infotrieve]

17. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, Busse R. Cytochrome P4502C is an EDHF synthase in coronary arteries. Nature. 1999; 401: 493–497.[CrossRef][Medline] [Order article via Infotrieve]

18. Bolz SS, Fisslthaler B, Pieperhoff S, de Wit C, Fleming I, Busse R, Pohl U. Antisense oligonucleotides against cytochrome P450 2C8 attenuate EDHF-mediated Ca²⁺ changes and dilation in isolated resistance arteries. FASEB J. 2000; 14: 255–260.[Abstract/Free Full Text]

19. Holtwick R, Gotthardt M, Skryabin B, Steinmetz M, Potthast R, Zetsche B, Hammer RE, Herz J, Kuhn M. Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci U S A. 2002; 99: 7142–7147.[Abstract/Free Full Text]

20. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci U S A. 1996; 93: 13176–13181.[Abstract/Free Full Text]

This article has been cited by other articles:

				C. de Wit Different pathways with distinct properties conduct dilations in the microcirculation in vivo Cardiovasc Res, October 31, 2009; (2009) cvp340v2. [Abstract] [Full Text] [PDF]

				S. E. Wolfle, V. J. Schmidt, J. Hoyer, R. Kohler, and C. de Wit Prominent role of KCa3.1 in endothelium-derived hyperpolarizing factor-type dilations and conducted responses in the microcirculation in vivo Cardiovasc Res, June 1, 2009; 82(3): 476 - 483. [Abstract] [Full Text] [PDF]

				S. Brahler, A. Kaistha, V. J. Schmidt, S. E. Wolfle, C. Busch, B. P. Kaistha, M. Kacik, A.-L. Hasenau, I. Grgic, H. Si, et al. Genetic Deficit of SK3 and IK1 Channels Disrupts the Endothelium-Derived Hyperpolarizing Factor Vasodilator Pathway and Causes Hypertension Circulation, May 5, 2009; 119(17): 2323 - 2332. [Abstract] [Full Text] [PDF]

				E. S. Buys, P. Sips, P. Vermeersch, M. J. Raher, E. Rogge, F. Ichinose, M. Dewerchin, K. D. Bloch, S. Janssens, and P. Brouckaert Gender-specific hypertension and responsiveness to nitric oxide in sGC{alpha}1 knockout mice Cardiovasc Res, July 1, 2008; 79(1): 179 - 186. [Abstract] [Full Text] [PDF]

				Y. N. Tallini, J. F. Brekke, B. Shui, R. Doran, S.-m. Hwang, J. Nakai, G. Salama, S. S. Segal, and M. I. Kotlikoff Propagated Endothelial Ca2+ Waves and Arteriolar Dilation In Vivo: Measurements in Cx40BAC GCaMP2 Transgenic Mice Circ. Res., December 7, 2007; 101(12): 1300 - 1309. [Abstract] [Full Text] [PDF]

				S. E. Wolfle, V. J. Schmidt, B. Hoepfl, A. Gebert, S. Alcolea, D. Gros, and C. de Wit Connexin45 Cannot Replace the Function of Connexin40 in Conducting Endothelium-Dependent Dilations Along Arterioles Circ. Res., December 7, 2007; 101(12): 1292 - 1299. [Abstract] [Full Text] [PDF]

				S. Weber, D. Bernhard, R. Lukowski, P. Weinmeister, R. Worner, J. W. Wegener, N. Valtcheva, S. Feil, J. Schlossmann, F. Hofmann, et al. Rescue of cGMP Kinase I Knockout Mice by Smooth Muscle Specific Expression of Either Isozyme Circ. Res., November 26, 2007; 101(11): 1096 - 1103. [Abstract] [Full Text] [PDF]

				B. Rodenwaldt, U. Pohl, and C. de Wit Endogenous and exogenous NO attenuates conduction of vasoconstrictions along arterioles in the microcirculation Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2341 - H2348. [Abstract] [Full Text] [PDF]

				M. P. Kunert, I. Drenjancevic-Peric, M. R. Dwinell, J. H. Lombard, A. W. Cowley Jr., A. S. Greene, A. E. Kwitek, and H. J. Jacob Consomic strategies to localize genomic regions related to vascular reactivity in the Dahl salt-sensitive rat Physiol Genomics, September 14, 2006; 26(3): 218 - 225. [Abstract] [Full Text] [PDF]

				H. Si, W.-T. Heyken, S. E. Wolfle, M. Tysiac, R. Schubert, I. Grgic, L. Vilianovich, G. Giebing, T. Maier, V. Gross, et al. Impaired Endothelium-Derived Hyperpolarizing Factor-Mediated Dilations and Increased Blood Pressure in Mice Deficient of the Intermediate-Conductance Ca2+-Activated K+ Channel Circ. Res., September 1, 2006; 99(5): 537 - 544. [Abstract] [Full Text] [PDF]

				F. Hofmann, R. Feil, T. Kleppisch, and J. Schlossmann Function of cGMP-Dependent Protein Kinases as Revealed by Gene Deletion Physiol Rev, January 1, 2006; 86(1): 1 - 23. [Abstract] [Full Text] [PDF]

				D. Siegl, M. Koeppen, S. E. Wolfle, U. Pohl, and C. de Wit Myoendothelial Coupling Is Not Prominent in Arterioles Within the Mouse Cremaster Microcirculation In Vivo Circ. Res., October 14, 2005; 97(8): 781 - 788. [Abstract] [Full Text] [PDF]

				F. Hofmann The Biology of Cyclic GMP-dependent Protein Kinases J. Biol. Chem., January 7, 2005; 280(1): 1 - 4. [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 44/6/952    most recent 01.HYP.0000147661.80059.cav1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Koeppen, M. Articles by de Wit, C. Search for Related Content PubMed PubMed Citation Articles by Koeppen, M. Articles by de Wit, C. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB NITRIC OXIDE Related Collections Endothelium/vascular type/nitric oxide